Literature DB >> 16642468

Family history of breast cancer and short-term effects of childbirths on breast cancer risk.

Grethe Albrektsen1, Ivar Heuch, Steinar Thoresen, Gunnar Kvåle.   

Abstract

The long-term protective effect of a pregnancy on breast cancer risk is preceded by a short-term adverse effect, possibly reflecting a promoting effect of pregnancy hormones. In the present study, we explore whether a family history of breast cancer modifies time-related effects of pregnancies, with special emphasis on the transient increase in risk of breast cancer shortly after birth. Our study cohort comprises 1,067,289 Norwegian women aged 20-74 years. The mean follow-up time was 18 years. Incidence rate ratios were estimated by Poisson regression analyses of person-years at risk. Of the 7,377 women diagnosed with breast cancer during follow-up, a total of 828 (11%) had a mother or a sister with breast cancer diagnosis. Women with a family history of breast cancer had a 2-3-fold higher risk of breast cancer than did women without any affected family member, highest for those with a relative diagnosed before they were 50 years. Similar to women without a familial excess risk, increasing parity was associated with an overall protective effect among women with a familial predisposition, regardless of age at diagnosis of the relative. Whereas women with no familial excess risk experienced a transient increase in risk mainly after late age births, women with a family history of breast cancer experienced an adverse effect of pregnancies also at younger ages. The present results give further support to the hypothesis that the adverse effect of a term birth can be explained by a promoting effect of pregnancy hormones.

Entities:  

Mesh:

Year:  2006        PMID: 16642468     DOI: 10.1002/ijc.22003

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

Review 1.  STAT signaling in mammary gland differentiation, cell survival and tumorigenesis.

Authors:  S Haricharan; Y Li
Journal:  Mol Cell Endocrinol       Date:  2013-03-28       Impact factor: 4.102

2.  Circulating estrogens and progesterone during primiparous pregnancies and risk of maternal breast cancer.

Authors:  Annekatrin Lukanova; Helja-Marja Surcel; Eva Lundin; Marjo Kaasila; Hans-Ake Lakso; Helena Schock; Anika Husing; Rudolf Kaaks; Pentti Koskela; Kjell Grankvist; Eero Pukkala; Anne Zeleniuch-Jacquotte; Matti Lehtinen; Paolo Toniolo
Journal:  Int J Cancer       Date:  2011-05-09       Impact factor: 7.396

3.  Histological type and grade of breast cancer tumors by parity, age at birth, and time since birth: a register-based study in Norway.

Authors:  Grethe Albrektsen; Ivar Heuch; Steinar Ø Thoresen
Journal:  BMC Cancer       Date:  2010-05-21       Impact factor: 4.430

Review 4.  Pregnancy associated breast cancer and pregnancy after breast cancer treatment.

Authors:  Emek Doğer; Eray Calışkan; Peter Mallmann
Journal:  J Turk Ger Gynecol Assoc       Date:  2011-12-01

5.  Breast Cancer Risk After Recent Childbirth: A Pooled Analysis of 15 Prospective Studies.

Authors:  Hazel B Nichols; Minouk J Schoemaker; Jianwen Cai; Jiawei Xu; Lauren B Wright; Mark N Brook; Michael E Jones; Hans-Olov Adami; Laura Baglietto; Kimberly A Bertrand; William J Blot; Marie-Christine Boutron-Ruault; Miren Dorronsoro; Laure Dossus; A Heather Eliassen; Graham G Giles; Inger T Gram; Susan E Hankinson; Judy Hoffman-Bolton; Rudolf Kaaks; Timothy J Key; Cari M Kitahara; Susanna C Larsson; Martha Linet; Melissa A Merritt; Roger L Milne; Valeria Pala; Julie R Palmer; Petra H Peeters; Elio Riboli; Malin Sund; Rulla M Tamimi; Anne Tjønneland; Antonia Trichopoulou; Giske Ursin; Lars Vatten; Kala Visvanathan; Elisabete Weiderpass; Alicja Wolk; Wei Zheng; Clarice R Weinberg; Anthony J Swerdlow; Dale P Sandler
Journal:  Ann Intern Med       Date:  2018-12-11       Impact factor: 25.391

Review 6.  The Premenopausal Breast Cancer Collaboration: A Pooling Project of Studies Participating in the National Cancer Institute Cohort Consortium.

Authors:  Hazel B Nichols; Minouk J Schoemaker; Lauren B Wright; Craig McGowan; Mark N Brook; Kathleen M McClain; Michael E Jones; Hans-Olov Adami; Claudia Agnoli; Laura Baglietto; Leslie Bernstein; Kimberly A Bertrand; William J Blot; Marie-Christine Boutron-Ruault; Lesley Butler; Yu Chen; Michele M Doody; Laure Dossus; A Heather Eliassen; Graham G Giles; Inger T Gram; Susan E Hankinson; Judy Hoffman-Bolton; Rudolf Kaaks; Timothy J Key; Victoria A Kirsh; Cari M Kitahara; Woon-Puay Koh; Susanna C Larsson; Eiliv Lund; Huiyan Ma; Melissa A Merritt; Roger L Milne; Carmen Navarro; Kim Overvad; Kotaro Ozasa; Julie R Palmer; Petra H Peeters; Elio Riboli; Thomas E Rohan; Atsuko Sadakane; Malin Sund; Rulla M Tamimi; Antonia Trichopoulou; Lars Vatten; Kala Visvanathan; Elisabete Weiderpass; Walter C Willett; Alicja Wolk; Anne Zeleniuch-Jacquotte; Wei Zheng; Dale P Sandler; Anthony J Swerdlow
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-06-09       Impact factor: 4.254

Review 7.  Pregnancy and breast cancer: when they collide.

Authors:  Traci R Lyons; Pepper J Schedin; Virginia F Borges
Journal:  J Mammary Gland Biol Neoplasia       Date:  2009-04-21       Impact factor: 2.673

8.  A functional genetic variant in fragile-site gene FATS modulates the risk of breast cancer in triparous women.

Authors:  Fangfang Song; Jun Zhang; Li Qiu; Yawen Zhao; Pan Xing; Jiachun Lu; Kexin Chen; Zheng Li
Journal:  BMC Cancer       Date:  2015-07-30       Impact factor: 4.430

9.  A case-control study of the joint effect of reproductive factors and radiation treatment for first breast cancer and risk of contralateral breast cancer in the WECARE study.

Authors:  Jennifer D Brooks; John D Boice; Roy E Shore; Anne S Reiner; Susan A Smith; Leslie Bernstein; Julia A Knight; Charles F Lynch; Esther M John; Kathleen E Malone; Lene Mellemkjaer; Rikke Langballe; Xiaolin Liang; Meghan Woods; Marc Tischkowitz; Patrick Concannon; Daniel O Stram
Journal:  Breast       Date:  2020-08-24       Impact factor: 4.380

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.